We dug in and did a survey for GLP-1
Although 503B facilities are required to comply with current good manufacturing practices, compounded drugs are not approved or reviewed by the FDA, meaning that the agency does not assess their safety, efficacy, or quality
For a cash-pay patient, that translates to roughly $1,548/year on the Microdose tier, $2,148$2,748/year on Semaglutide Injection, and $2,748$3,708/year on Tirzepatide Injection well below FDA-approved branded GLP-1s at retail list price (~$1,000$1,350/month before insurance)
In contrast, immunohistological studies, with little information on antibody specificity, report a homogenous pattern of GLP-1R staining in both the white and gray matter 24 , identifying GLP-1R-immunoreactive cells primarily as microglia 24,25,26 , but also as neurons 24,25,26,27,28 , oligodendrocytes 24 , and astrocytes 25
How many units is 12.5 mg of tirzepatide
46.5% and 66.2%, respectively)